000			01175 a2200325 4500
005			20250514225912.0
264		0	_c20050614
008			200506s 0 0 fre d
022			_a1769-6917
040			_aNLM _beng _cNLM
100	1		_aEschwege, Pascal
245	0	0	_a[Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers]. _h[electronic resource]
260			_bBulletin du cancer _cMay 2004
300			_aS113-6 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCyclooxygenase 2
650	0	4	_aCyclooxygenase 2 Inhibitors
650	0	4	_aCyclooxygenase Inhibitors _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGenital Neoplasms, Female _xdrug therapy
650	0	4	_aGenital Neoplasms, Male _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMembrane Proteins
650	0	4	_aProstaglandin-Endoperoxide Synthases _xmetabolism
650	0	4	_aUrogenital Neoplasms _xdrug therapy
773	0		_tBulletin du cancer _gvol. 91 Suppl 2 _gp. S113-6
999			_c15561899 _d15561899